Ginkgo bioworks announces participation in goldman sachs 43rd annual global healthcare conference

Boston , june 10, 2022 /prnewswire/ -- ginkgo bioworks (nyse: dna), the leading horizontal platform for cell programming, announced today that management is scheduled to participate in goldman sachs' 43rd annual global healthcare conference, on june 15, 2022, at 10:40 a.m. pt. further details, a webcast link, and a replay of the presentation, if available, will be posted on the company's investor relations website at  https://investors.ginkgobioworks.com/events.
DNA Ratings Summary
DNA Quant Ranking